8-K: Cannabis Bioscience International Secures $66,000 Bridge Financing Through Note Purchase Agreement

Cannabis Bioscience International Holdings, Inc. has entered into a Securities Purchase Agreement to issue a $66,000 bridge note to 1800 Diagonal Lending LLC.

Summary

• Cannabis Bioscience International Holdings, Inc. has secured a $66,000 bridge loan through a note purchase agreement with 1800 Diagonal Lending LLC.
• The note has an original issue discount of $11,000, resulting in net proceeds of $55,000 for the company.
• The company also incurred $5,000 in expenses for legal fees and due diligence.
• The note carries a 13% initial interest charge of $8,580.
• The total repayment amount is $74,580, to be paid in five installments between September 2024 and January 2025.
• The note is convertible into common stock upon default at a conversion price of 65% of the lowest trading price in the 10 days prior to conversion.
• The company is required to reserve three times the number of shares issuable upon full conversion, initially 435,164,835 shares.
• The net proceeds of $50,000 will be used for general working capital purposes.

Sentiment

Score: 3

Explanation: The document indicates a high-risk financing agreement with unfavorable terms for the company, including a significant discount, high interest rates, and potential dilution. This suggests a negative outlook from an investment perspective.

Positives

• The company has secured additional funding for general working capital purposes.
• The company has the option to prepay the note in full at any time without penalty.

Negatives

• The note includes a significant original issue discount of $11,000.
• The company is required to pay a 13% initial interest charge of $8,580.
• The note has a high default interest rate of 22% per annum.
• The note is convertible into common stock upon default, potentially diluting existing shareholders.
• The company is required to reserve a large number of shares for potential conversion, which could further dilute existing shareholders.
• The company is subject to various events of default, including failure to maintain its stock listing or comply with SEC reporting requirements.

Risks

• The company faces the risk of default if it fails to make timely payments or breaches any covenants.
• Default on the note triggers a 150% repayment obligation and potential conversion of the debt into shares at a discount.
• The conversion of the note could significantly dilute existing shareholders.
• The company's ability to meet its repayment obligations is dependent on its financial performance.
• The company is subject to various events of default, including failure to maintain its stock listing or comply with SEC reporting requirements.
• The company is subject to a cross-default clause with other agreements with the lender.

Future Outlook

The company intends to use the net proceeds from the note for general working capital purposes.

Management Comments

• The company has entered into a Securities Purchase Agreement with 1800 Diagonal Lending LLC.

Industry Context

This type of bridge financing is common for companies seeking short-term capital, particularly in sectors like cannabis where access to traditional financing may be limited. The terms of the agreement, including the discount and conversion features, are typical of such arrangements.

Comparison to Industry Standards

• The 13% initial interest rate is relatively high, reflecting the risk associated with lending to a company in the cannabis sector.
• The 22% default interest rate is also high, indicating the lender's focus on risk mitigation.
• The conversion feature at 65% of the lowest trading price is a common mechanism in bridge financing, providing the lender with potential upside if the company's stock price increases.
• The requirement to reserve three times the number of shares issuable upon conversion is a standard practice to ensure sufficient shares are available for conversion.
• Compared to other similar financings, the terms are relatively standard for a high-risk, short-term loan.

Stakeholder Impact

• Shareholders face potential dilution from the conversion of the note.
• The company's financial stability is impacted by the debt obligations.
• The lender has a significant stake in the company's performance due to the conversion rights.

Next Steps

• The company will use the proceeds for general working capital.
• The company is required to make five installment payments between September 2024 and January 2025.
• The company must maintain a sufficient reserve of shares for potential conversion of the note.

Key Dates

Keywords

bridge financing, promissory note, securities purchase agreement, convertible note, working capital, default, conversion rights, dilution, interest, lender